Skip to content
TheChatArchiveThe Chat Archive
Geminigemini-2.5-pro· GoogleHugging Face LMArena Human Preference 140K

who runs c19early

From a Chatbot Arena battleThe same person sent this prompt to two anonymous models at once. Compare it with grok-3-mini-beta’s answer.
  1. User

    who runs c19early

  2. Gemini Assistant

    Based on the information available on the website itself and reporting from various sources, C19early.com is run by an anonymous individual who uses the pseudonym "Covid19Crusher" along with a team of anonymous volunteers.

    Here is a more detailed breakdown:

    The Key Figure: "Covid19Crusher"

    • Anonymity: The primary creator and operator of the site remains anonymous, identifying only as "Covid19Crusher."
    • Self-Described Background: On the website, this individual has described themselves as a scientist with a multi-decade career in the biotech and pharmaceutical industries. They claim this background gives them the expertise to analyze scientific studies and data.
    • Motivation: Their stated goal was to create a resource that aggregates all available studies on early treatments for COVID-19, particularly repurposed drugs like ivermectin and hydroxychloroquine. They argue that this information was being suppressed or ignored by mainstream public health organizations and media.

    The Team

    • The site's "About" page states that it is a collaborative effort run by a team of volunteer doctors, scientists, data analysts, and translators from around the world.
    • Like the main operator, these contributors are largely anonymous or use pseudonyms.

    Purpose and Stance of the Website

    C19early.com is not a neutral scientific database. It is an advocacy website with a clear point of view.

    • Focus: It exclusively focuses on treatments for COVID-19, with a strong emphasis on early, outpatient treatment.
    • Stance: The site is highly critical of the mainstream medical consensus, public health bodies (like the CDC and WHO), and pharmaceutical companies. It promotes the view that effective and inexpensive early treatments were deliberately suppressed in favor of more expensive, novel drugs and vaccines.
    • Methodology: The site compiles studies—including observational studies, randomized controlled trials (RCTs), and pre-prints—and often presents its own meta-analyses and data visualizations to argue for the effectiveness of certain treatments.

    Controversy and Criticism

    The website and its operators have been the subject of significant criticism from the mainstream scientific and medical communities for several reasons:

    • Bias and Cherry-Picking: Critics argue that the site's analyses are biased and that they "cherry-pick" data, often including low-quality or even fraudulent studies (like the now-retracted Surgisphere study) to support their conclusions.
    • Lack of Peer Review: The analyses presented on the site are not subjected to the rigorous, independent peer-review process required by reputable scientific journals.
    • Anonymity: The anonymity of the operators makes it impossible to verify their credentials, expertise, or potential conflicts of interest.
    • Spreading Misinformation: Public health officials and fact-checkers have identified the site as a significant source of medical misinformation for promoting unproven treatments and undermining confidence in established public health guidance.

    In summary, C19early.com is run by an anonymous group of activists, led by "Covid19Crusher," who advocate for the use of repurposed drugs for the early treatment of COVID-19. While supporters see it as a vital resource for suppressed information, critics view it as a biased platform that promotes unproven therapies and medical misinformation.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.